Expert Interview
Digging into the Phase 3 CAHtalyst study of Neurocrine's crinecerfont in adults for the treatment of CAH due to 21-OHD
Ticker(s): NBIXInstitution: University of Michigan
- Professor of Medicine in Metabolism, Endocrinology & Diabetes (MEND) and Director of the MEND Fellowship Program at the University of Michigan.
- Manages around 50 patients with congenital adrenal hyperplasia (CAH) with 21OHD patients.
- Clinical focus on the care of adults with genetic disorders of steroid biosynthesis and action; Translational research focus on molecular and genetic mechanisms of modifier genes in 21-hydroxylase deficiency and has worked on clinical trials and translational investigations on CAH.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
